ATE526917T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number
ATE526917T1
ATE526917T1 AT01916128T AT01916128T ATE526917T1 AT E526917 T1 ATE526917 T1 AT E526917T1 AT 01916128 T AT01916128 T AT 01916128T AT 01916128 T AT01916128 T AT 01916128T AT E526917 T1 ATE526917 T1 AT E526917T1
Authority
AT
Austria
Prior art keywords
membrane
nail
forming
solvent
solution
Prior art date
Application number
AT01916128T
Other languages
English (en)
Inventor
Robert Gyurik
Original Assignee
Cpex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cpex Pharmaceuticals Inc filed Critical Cpex Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE526917T1 publication Critical patent/ATE526917T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01916128T 2000-02-16 2001-02-16 Pharmazeutische zusammensetzung ATE526917T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE526917T1 true ATE526917T1 (de) 2011-10-15

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916128T ATE526917T1 (de) 2000-02-16 2001-02-16 Pharmazeutische zusammensetzung

Country Status (17)

Country Link
EP (1) EP1257248B1 (de)
JP (1) JP2005503318A (de)
KR (2) KR20080049148A (de)
CN (1) CN1422142A (de)
AT (1) ATE526917T1 (de)
AU (2) AU4318901A (de)
BR (1) BR0108438A (de)
CA (1) CA2400178A1 (de)
HU (1) HUP0204555A3 (de)
MA (1) MA26883A1 (de)
MX (1) MXPA02008072A (de)
NO (1) NO20023866L (de)
NZ (1) NZ520749A (de)
PL (1) PL357111A1 (de)
TW (1) TWI232756B (de)
WO (1) WO2001060325A1 (de)
ZA (1) ZA200206553B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
JP2005538156A (ja) 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
PL2106805T3 (pl) * 2003-03-21 2011-10-31 Nexmed Holdings Inc Przeciwgrzybicza powłoka na paznokcie
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
EP1947938A4 (de) * 2005-11-02 2009-07-01 Cpex Pharmaceuticals Inc Makrocyclische formulierungen für die transmembranale arzneistoffabgabe
WO2007070643A2 (en) * 2005-12-14 2007-06-21 Zars, Inc. Compositions and methods for treating dermatological conditions
EP1970076A4 (de) 2005-12-28 2012-12-12 Teikoku Seiyaku Kk Pharmazeutische zusammensetzung zum auftragen auf einen nagel
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
WO2010108060A1 (en) * 2009-03-20 2010-09-23 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE69216446T2 (de) * 1991-03-13 1997-06-26 Firmenich & Cie Verfahren zur Herstellung von 15-Pentadecanolid oder von an diesem Makrolid reichen Gemischen
CA2211004A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
US6224887B1 (en) * 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
AU4318901A (en) 2001-08-27
PL357111A1 (en) 2004-07-12
HUP0204555A3 (en) 2004-06-28
JP2005503318A (ja) 2005-02-03
AU2001243189B2 (en) 2005-06-09
CN1422142A (zh) 2003-06-04
WO2001060325A1 (en) 2001-08-23
EP1257248B1 (de) 2011-10-05
EP1257248A4 (de) 2007-10-03
MXPA02008072A (es) 2004-04-05
KR20080049148A (ko) 2008-06-03
EP1257248A1 (de) 2002-11-20
NZ520749A (en) 2004-06-25
CA2400178A1 (en) 2001-08-23
BR0108438A (pt) 2003-04-01
NO20023866L (no) 2002-10-01
MA26883A1 (fr) 2004-12-20
KR20030016227A (ko) 2003-02-26
HUP0204555A2 (en) 2003-05-28
ZA200206553B (en) 2003-11-17
TWI232756B (en) 2005-05-21
NO20023866D0 (no) 2002-08-15

Similar Documents

Publication Publication Date Title
ATE526917T1 (de) Pharmazeutische zusammensetzung
EA200500084A1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента
JP2005503318A5 (de)
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
PT743860E (pt) Preparacao de microcapsulas ocas
MXPA03005375A (es) Formulacion repelente de insectos que contiene solventes polares, que tiene baja viscosidad y de entrega mediante dispositivo piezoelectrico.
EA199900991A1 (ru) Медицинские аэрозольные препараты
DE60123793D1 (de) Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
DE69410634D1 (de) Anatomisches und biologisches konservierungsmittel und verbesserte einbalsamierungszusammensetzung und -verfahren
SG166105A1 (en) Antifungal composition
BR0205329A (pt) Composição lìquida formadora de pelìcula
CO4770947A1 (es) Composiciones antimicrobianas que contienen alcohol c3-c6
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
GEP20022628B (en) Nimesulide Gel Systems For Topical Use
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
ES2111272T3 (es) Mezclas herbicidas.
DE69828615D1 (de) Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
DE60119914D1 (de) Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden
JPH03505835A (ja) 経皮ドラッグデリバリーシステム
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
ATE214269T1 (de) Oral anzuwendende flüssige arzneilösung
JP2008214277A (ja) ジェルスプレー用エアゾール組成物
AR002981A1 (es) Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties